1. Home
  2. GPMT vs ITRM Comparison

GPMT vs ITRM Comparison

Compare GPMT & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$2.45

Market Cap

118.0M

Sector

Real Estate

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.37

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPMT
ITRM
Founded
2015
2015
Country
United States
Ireland
Employees
33
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
24.3M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
GPMT
ITRM
Price
$2.45
$0.37
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$3.13
$9.00
AVG Volume (30 Days)
159.2K
731.7K
Earning Date
11-05-2025
02-06-2026
Dividend Yield
8.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.74
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$0.36
52 Week High
$3.23
$2.10

Technical Indicators

Market Signals
Indicator
GPMT
ITRM
Relative Strength Index (RSI) 30.69 32.72
Support Level $2.48 $0.44
Resistance Level $2.60 $0.49
Average True Range (ATR) 0.08 0.04
MACD -0.03 0.00
Stochastic Oscillator 13.51 0.78

Price Performance

Historical Comparison
GPMT
ITRM

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: